Santhera Pharmaceuticals Stock Forward View - Rate Of Daily Change
| SANN Stock | CHF 14.12 -0.42 -2.89% |
Santhera Pharmaceuticals's Rate Of Daily Change reference data is presented on this page, derived from the application of the forecasting model to historical closing prices. Projected values and accuracy measures are included for reference.
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period. The Rate Of Daily Change reference information for Santhera Pharmaceuticals is based on available price data and is intended for informational purposes. Rate Of Daily Change Analysis Today
Santhera Pharmaceuticals Holding has current Rate Of Daily Change of 0.97. Rate Of Daily Change (RDOC) indicator calculates rate of change of a given period over the current closing price of Santhera Pharmaceuticals.| Previous Rate Of Daily Change | Rate Of Daily Change | Trend |
| 0.98 | 0.97 |
| Volatility | Backtest | Information Ratio |
Santhera Pharmaceuticals Trading Date Momentum
| On March 20 2026 Santhera Pharmaceuticals Holding was traded for 14.12 at the closing time. The highest price during the trading period was 14.40 and the lowest recorded bid was listed for 13.90 . The volume for the day was. This history from March 20, 2026 did not result in any price rise and fall. The trading price change to the current price is 0.57% . |
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
| Compare Santhera Pharmaceuticals to competition |
Other Forecasting Options for Santhera Pharmaceuticals
For any investor considering Santhera, Santhera Pharmaceuticals' price movement is the central factor in determining investment viability. The noise present in Santhera Stock price charts can distort investment decisions if not properly addressed.Santhera Pharmaceuticals Related Equities
The following equities are related to Santhera Pharmaceuticals within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Santhera Pharmaceuticals against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Santhera Pharmaceuticals Market Strength Events
Market strength indicators for Santhera Pharmaceuticals stock help investors evaluate the security's behavior relative to ongoing market conditions. These tools support better market timing and help identify entry and exit signals for Santhera Pharmaceuticals Holding.
| Accumulation Distribution | 3866.15 | |||
| Daily Balance Of Power | -0.84 | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 14.15 | |||
| Day Typical Price | 14.14 | |||
| Price Action Indicator | -0.24 | |||
| Period Momentum Indicator | -0.42 |
Santhera Pharmaceuticals Risk Indicators
The analysis of Santhera Pharmaceuticals' basic risk indicators is a key input for accurate price forecasting and sound investment decisions. Understanding the risk in Santhera Pharmaceuticals' investment allows investors to make informed choices about accepting or mitigating that exposure.
| Mean Deviation | 2.74 | |||
| Semi Deviation | 2.94 | |||
| Standard Deviation | 3.57 | |||
| Variance | 12.71 | |||
| Downside Variance | 10.36 | |||
| Semi Variance | 8.65 | |||
| Expected Short fall | -3.27 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Santhera Pharmaceuticals
The amount of media and story coverage tied to Santhera Pharmaceuticals Holding can signal where market attention is concentrating at the moment. A disciplined read of coverage separates durable relevance from temporary noise.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
Santhera Pharmaceuticals Short Properties
Reviewing short-oriented indicators for Santhera Pharmaceuticals Holding is useful because long and short participants often create very different signals for timing and volatility. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 11.4 M | |
| Cash And Short Term Investments | 40.9 M |
Additional Tools for Santhera Stock Analysis
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stocks Directory Find actively traded stocks across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |